Rocuronium prevents succinylcholine-induced fasciculations

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Succinylcholine is a common muscle relaxant used for endotracheal intubation.
• Muscle fasciculations are an undesirable side effect of succinylcholine administration.
• Rocuronium is a non-depolarizing neuromuscular blocker that can be used for pretreatment.

Purpose of the Study:

• To evaluate the efficacy of rocuronium pretreatment in mitigating succinylcholine-induced fasciculations.
• To assess the impact of rocuronium pretreatment on neuromuscular blockade characteristics and intubating conditions.

Main Methods:

• A double-blind, randomized study involving 60 patients.
• Three groups: rocuronium 0.05 mg/kg at 3 min before succinylcholine (ROC-3 min), 1.5 min before (ROC-1.5 min), or no pretreatment (NO ROC).
• Fasciculations, intubating conditions, and neuromuscular block at the adductor pollicis were assessed.

Main Results:

• Rocuronium pretreatment significantly reduced the incidence and intensity of fasciculations compared to no pretreatment (9-30% vs. 83%).
• No significant difference in fasciculation reduction was observed between 1.5 min and 3 min pretreatment intervals.
• Intubating conditions, onset, and duration of succinylcholine blockade remained comparable across all groups.

Conclusions:

• Rocuronium pretreatment (0.05 mg/kg) administered 1.5 or 3 minutes prior to succinylcholine effectively reduces fasciculations.
• Pretreatment does not adversely affect intubating conditions or the overall neuromuscular blockade profile of succinylcholine.